Expression of the Extra Domain B of Fibronectin, a Marker of Angiogenesis, in Head and Neck Tumors
- 1 July 2003
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 113 (7), 1231-1237
- https://doi.org/10.1097/00005537-200307000-00023
Abstract
Objectives/Hypothesis The extra domain B (ED-B) of fibronectin, a naturally occurring marker of tissue remodeling and angiogenesis, is expressed in the majority of aggressive solid human tumors, wher...Keywords
This publication has 22 references indexed in Scilit:
- Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculatureNature Biotechnology, 2002
- Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformNature Biotechnology, 1997
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesisInternational Journal of Cancer, 1994
- Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissuesInternational Journal of Cancer, 1994
- Oncofetal fibronectins in oral carcinomas:APMIS, 1994
- A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.The Journal of cell biology, 1989
- FIBRONECTIN AND ITS RECEPTORSAnnual Review of Biochemistry, 1988
- Transformed human cells release different fibronectin variants than do normal cells.The Journal of cell biology, 1986
- Pericellular Matrix in Malignant TransformationAdvances in Cancer Research, 1982